Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-24-028740

EVP R&D, Chief Medical Officer sold 9,221 shares at $31.50 ($290,462)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-05 Sale : show line 1 in the form 10b5-1 −9,221 $31.50 $290,462 59,730 D
Open-market sales · 9,221 sh · avg $31.50 · $290,462
Loading xslF345X05/form4.xml…